Evidence for a DNA Methylation Signature of ASD in Cord BloodNews
A new study led by UC Davis MIND Institute researchers found a distinct DNA methylation signature in the cord blood of newborns who were eventually diagnosed with autism spectrum disorder (ASD). This signature mark spanned DNA regions and genes linked to early fetal neurodevelopment. The findings may hold clues for early diagnosis and intervention.Read more
State-of-the-Art AI Methods Used To Study Alzheimer’sNews
A massive problem like Alzheimer's disease --which affects nearly 50 million people worldwide--requires bold solutions. New funding expected to total $17.8 million, awarded to USC's Mark and Mary Stevens Neuroimaging Informatics Institute and its collaborators, is one key piece of that puzzle.
Like Humans, Aging Chimpanzees Value Friendship and CompanyNews
Old friends get together to relax, share meals, and trust and support each other. In the latter part of life, these friendships are highly valued. Recent research shows this happens in chimpanzees as well as humans.
Is Learning Impacted by Indoor Environment?News
In the analysis published in Indoor Air, the team looked at indoor air, thermal, acoustic, and lighting conditions. The collected evidence from 21 studies showed that the indoor environmental quality can contribute to the quality of learning.Read more
Major Step Toward Angelman Syndrome Gene TherapyNews
Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists at the UNC School of Medicine show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures and treat deficits in an animal model of Angelman syndrome.
Personalized Medicine Model Aiming To Improve Diagnosis and Treatment of Chronic DiseasesArticle
To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.Read more
What Does COVID-19 Do to the Nervous System?Article
The first widespread reports that SARS-CoV-2 might be affecting our nervous system were quite innocuous. But over the following months, reports of far more severe neurological side effects emerged. In this article, we take a look at the neurological symptoms of COVID-19.Read more
AI Bridges Multiple Sclerosis Patients to Relevant Clinical TrialsArticle
Clinical trials are a significant milestone in the development of innovative drugs and therapies for people diagnosed with different medical conditions including multiple sclerosis (MS). In this article, we examine how technology can make it easier for people to find and enroll on clinical trials.Read more
Pushing the Envelope: Subcellular and High-Throughput Cell ImagingArticle
As microscopes have improved, so too has their resolution and their ability to image cellular substructure, even down to the single-molecule level. Researchers can now investigate the carefully orchestrated trafficking and interaction of organelles, cargo, and biomolecules that sustain cellular life.Read more
What's the Physiological Relevance? A Profile of Oded RechaviArticle
A profile piece exploring the life and career of the molecular biologist Professor Oded Rechavi.Read more